CRISPR Clinical Trials And Regulatory Approval Of CRISPR Therapy Drugs

Are you currently navigating the intricate regulatory landscape in order to move your CRISPR therapies through clinical trials?

CRISPR therapy drugs have been on the rise and are already transforming the lives of patients. However, bringing CRISPR therapy products from the bench to the clinic demands both scientific and regulatory expertise. In this e-book you will learn more about identifying and validating a target, testing in human subjects, changing FDA guidance and regulatory trends, regulatory documentation and more.

Download this E-book below and check out the rest of Synthego's Preclinical Resource Collection.

• Discovery To Clinic: CRISPR-Based Therapies And Diagnostics
• CRISPR Cell And Gene Therapies: Key Challenges In Clinical Development
• INDe sgRNAs For Preclinical Safety, Toxicity, And Efficacy Studies

As well as our Clinical Resource Collection:

• CRISPR Cell And Gene Therapies: Key Challenges In Clinical Development
• GMP sgRNA Manufacturing For Seamless Transitions From Discovery To Delivery
• New Next-Generation GMP Facility